323990.KQ KOE
Vaxcell-Bio Therapeutics Co., Ltd.
1W: +1.8%
1M: -15.5%
3M: -12.2%
YTD: -58.0%
1Y: -54.3%
3Y: -86.2%
5Y: -94.3%
₩4,285.00 ($3.19)
-25.00 (-0.58%)
Weekly Expected Move ±7.6%
₩3630
₩3958
₩4285
₩4612
₩4940
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩99.3B ($74.0M)
52W Range3350-11520
Volume48,792
Avg Volume172,582
Beta0.43
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJae-Jung Lee
Employees81
SectorHealthcare
IndustryBiotechnology
IPO Date2020-09-22
Websitevaxcell-bio.com
12-55, Sandan-gil
Hwasun, SJ 58141
KR
Hwasun, SJ 58141
KR
82 6 1373 0046
About Vaxcell-Bio Therapeutics Co., Ltd.
Established in 2010, Vaxcell-Bio Therapeutics Co., Ltd. specializes in the research, development, and commercialization of immune cell-based therapies designed to treat cancer, primarily operating within South Korea. The company's main base of operations is located in Hwasun-eup, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found